Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Citigroup

Read How Analysts Reacted To MongoDB Post Q1 Earnings Beat

Analysts appreciated MongoDB, Inc's (NASDAQ:MDB) Q1 beat but cut the price target to reflect macro headwinds. Needham analyst Mike Cikos maintained MongoDB with a Buy rating and lowered the price target from $362 to $310. The price target change reflected the declines in the broader stock market. Cikos acknowledged MongoDB's strong 1QF23 feat outperforming guidance and expectations.…

Benzinga

Looking At Citigroup's Recent Whale Trades

Someone with a lot of money to spend has taken a bullish stance on Citigroup (NYSE:C). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

10 Analysts Have This to Say About Citigroup

Within the last quarter, Citigroup (NYSE:C) has observed the following analyst ratings:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022

Upgrades

Benzinga

CNBC's Final Trades: Charter Communications, T Rowe Price Group, Citigroup And This Shorting Opportunity

On CNBC’s “Halftime Report Final Trades,” Karen Firestone of Aureus Asset Management said that Charter Communications Inc (NASDAQ: CHTR) is “a straight, pure cable co

Benzinga

Hedge fund of Blackpool FC owner Simon Sadler 'cut off' by Bank of America and Citigroup over trading concerns

Mr Sadler set up Segantii Capital Management in 2007

Birmingham Post

Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022

Upgrades

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Check Out What Whales Are Doing With Citigroup

Benzinga

Warren Buffett’s portfolio: Here are the stocks Berkshire Hathaway is buying or selling

Warren Buffett is arguably the world’s most famous investor, and his investment moves are closely followed. Each quarter, the company he runs, Berkshire Hathaway, discloses its current holdings to shareholders.

Tribune News Service

30 Stocks Moving In Monday's Mid-Day Session

Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.

Benzinga

Citigroup Downgrades Ralph Lauren: Here's What You Need To Know

Citigroup downgraded its rating of Ralph Lauren (NYSE:RL) to Neutral with a price target of $98.00, changing its price target from $140.00 to $98.00. Shares of Ralph Lauren are trading down 1.23% over the last 24 hours, at $92.09 per share.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022

Benzinga

Georgia Tech grad Steve Hall has highest ambitions for ultimate disc league

ATLANTA — In 2012, Steve Hall was 46 and in a stage of life not unfamiliar to Georgia Tech graduates of his age. A chemical engineering graduate with an MBA from Emory, Hall was running his own private-equity firm in Charlotte, N.C., after 13 years in New York in the…

Tribune News Service

Citigroup Maintains Buy Rating for Autodesk: Here's What You Need To Know

Citigroup has decided to maintain its Buy rating of Autodesk (NASDAQ:ADSK) and lower its price target from $286.00 to $264.00. Shares of Autodesk are trading down 1.6% over the last 24 hours, at $190.62 per share. A move to $264.00 would account for a 38.5% increase from the current share…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What Are Whales Doing With Johnson & Johnson

Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Citigroup Maintains Neutral Rating for Old Dominion Freight Line: Here's What You Need To Know

Citigroup has decided to maintain its Neutral rating of Old Dominion Freight Line (NASDAQ:ODFL) and lower its price target from $295.00 to $265.00. Shares of Old Dominion Freight Line are trading up 1.76% over the last 24 hours, at $240.63 per share.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 19, 2022

Upgrades

Benzinga

Citigroup Maintains Buy Rating for HUYA: Here's What You Need To Know

Citigroup has decided to maintain its Buy rating of HUYA (NYSE:HUYA) and lower its price target from $6.80 to $6.00. Shares of HUYA are trading up 1.88% over the last 24 hours, at $4.08 per share. A move to $6.00 would account for a 47.24% increase from the current share…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

More Bullish Bets On Citi After Warren Buffett Buys Large Stake

Through his company Berkshire Hathaway Inc (NYSE: BRK-A), legendary investor Warren Buffett has purchased 55.2 million shares of Citigroup Inc’s (NYSE: C) shares, comprising around 2.8% of the company&r

Benzinga

Check Out What Whales Are Doing With Citigroup

Someone with a lot of money to spend has taken a bearish stance on Citigroup (NYSE:C). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Warren Buffett Exits Wells Fargo And Buys Stake In Its Rival Bank

Berkshire Hathaway Inc (NYSE: BRK-B) bought $3 billion worth of shares in Citigroup Inc (NYSE: C) in Q1, giving the group a stake of about 2.8%, according to filings with regulators.

StockNews.com

Citigroup: Buy, Sell, or Hold?

The shares of the renowned megabank Citigroup (C) have slumped more than 20% in price this year. Furthermore, with geopolitical issues taking a toll on the global economy and Wall Street seeing a risk of default by major banks, is C a smart investment now? Read on.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022

Upgrades

Benzinga

Citigroup Maintains Buy Rating for Ultragenyx Pharmaceutical: Here's What You Need To Know

Citigroup has decided to maintain its Buy rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) and lower its price target from $150.00 to $146.00. Shares of Ultragenyx Pharmaceutical are trading up 2.9% over the last 24 hours, at $53.30 per share.

Benzinga

How Is The Market Feeling About Citigroup?

Citigroup's (NYSE:C) short percent of float has risen 4.8% since its last report. The company recently reported that it has 47.52 million shares sold short, which is 2.4% of all regular shares that are available for trading.

1 … 28 29 30 31

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.